机器人辅助与开放根治性膀胱切除术在膀胱癌患者中的多中心比较效果研究
这项在19家荷兰中心开展的前瞻性比较效果研究纳入348例膀胱癌患者(开放组168例,机器人组180例),比较开放与机器人辅助根治性膀胱切除术的90天并发症、健康相关生活质量及临床结局。结果显示两组任何级别并发症发生率分别为63%和56%,风险差-6.4%(95%CI -17至4.5),主要并发症和健康相关生活质量均无统计学显著差异。
要点
- 两组90天任何级别并发症风险差-6.4%(95%CI -17至4.5),无统计学显著差异。
- 两组主要并发症风险差0.9%(95%CI -7.0至8.8),无统计学显著差异。
- 健康相关生活质量分析未显示开放与机器人辅助手术间有统计学显著差异。
核心结论
- 多中心比较效果研究显示开放与机器人辅助根治性膀胱切除术在并发症和健康相关生活质量方面无统计学显著差异。
研究设计与样本
- 前瞻性比较效果研究,在19家擅长开放或机器人辅助根治性膀胱切除术的荷兰中心开展。
- 随访安排在术后30天、90天和365天,采用标准化围手术期方案。
- 主要结局为90天任何级别并发症,采用Clavien-Dindo分级;通过倾向性评分逆概率治疗加权调整基线差异。
主要发现
- 90天任何级别并发症发生率开放组63%、机器人组56%,风险差-6.4%(95%CI -17至4.5)。
- 主要并发症发生率开放组15%、机器人组16%,风险差0.9%(95%CI -7.0至8.8)。
- 总次要并发症发生率开放组57%、机器人组49%,风险差-7.6%(95%CI -19至3.6)。
- 健康相关生活质量分析未显示两组间有统计学显著差异。
- 部分次要结局的差异分别有利于机器人辅助或开放手术。
临床怎么用
- 在擅长各自技术的中心,开放与机器人辅助根治性膀胱切除术的90天并发症和健康相关生活质量相近,术式选择可综合考虑中心经验与患者情况。
局限性
- 研究设计的主要固有缺陷为残余混杂。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Radical cystectomy with pelvic lymph node dissection (PLND) and urinary diversion in patients with bladder cancer is known for its high risk of complications. Although open radical cystectomy (ORC) is regarded as the standard treatment, robot-assisted radical cystectomy (RARC) is increasingly used in practice, despite the fact that high-quality evidence comparing the effectiveness of both techniques is lacking. OBJECTIVE: To study the effectiveness of RARC compared with that of ORC, in terms of 90 d complications (Clavien-Dindo), health-related quality of life (HRQOL), and clinical outcomes. DESIGN, SETTING, AND PARTICIPANTS: A prospective comparative effectiveness study was conducted in 19 Dutch centres, expert in either ORC or RARC. Follow-up visits were scheduled at 30, 90, and 365 d. INTERVENTION: Standard ORC or RARC with PLND, using a standardised perioperative protocol. OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: The primary outcome was any-grade complications after 90 d. Secondary outcomes included HRQOL, complications (minor, major, 30 d, and 365 d), and clinical outcomes. Differences were calculated as risk differences (RDs) between the groups with 95% confidence intervals (CIs), adjusted for potential baseline differences by means of propensity score-based inverse probability of treatment weighting. RESULTS AND LIMITATIONS: Between March 2016 and November 2018, 348 patients were included (n = 168 for ORC, n = 180 for RARC). At 90 d, any-grade complication rates were 63% for ORC and 56% for RARC (RD -6.4%, 95% CI -17 to 4.5). Major complication rates were 15% for ORC and 16% for RARC (RD 0.9%, 95% CI -7.0 to 8.8). Total minor complication rates were 57% for ORC and 49% for RARC (RD -7.6%, 95% CI -19 to 3.6). Analyses showed no statistically significant differences in HRQOL between ORC and RARC. Some differences were found in the secondary outcomes in favour of either RARC or ORC. The major drawback inherent to the design comprises residual confounding. CONCLUSIONS: This multicentre comparative effectiveness study showed no statistically significant differences between ORC and RARC in terms of complications and HRQOL. PATIENT SUMMARY: This multicentre study did not show differences in overall complication rates, health-related quality of life, mortality, and clinical and oncological outcomes between open and robot-assisted radical cystectomy in bladder cancer patients.
引用
- Wijburg CJ, Michels CTJ, Hannink G, et al. Robot-assisted Radical Cystectomy Versus Open Radical Cystectomy in Bladder Cancer Patients: A Multicentre Comparative Effectiveness Study. Eur Urol. 2021. PMID: 33446375. doi:10.1016/j.eururo.2020.12.023
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。